Technical Analysis for SPRY - ARS Pharmaceuticals, Inc.
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Weak or Absent | Up | Down | Down |
Date | Alert Name | Type | % Chg |
---|---|---|---|
50 DMA Resistance | Bearish | -0.11% | |
Outside Day | Range Expansion | -0.11% | |
Gapped Up | Strength | -0.11% | |
50 DMA Resistance | Bearish | -1.22% | |
NR7 | Range Contraction | -1.22% | |
NR7-2 | Range Contraction | -1.22% | |
Narrow Range Bar | Range Contraction | -1.22% | |
Earnings Movers | Other | -1.22% | |
MACD Bearish Signal Line Cross | Bearish | -0.22% | |
Crossed Above 20 DMA | Bullish | -0.22% |
Alert | Time |
---|---|
20 DMA Support | 1 minute ago |
Fell Below Previous Day's Low | 1 minute ago |
10 DMA Resistance | about 24 hours ago |
Up 2% | about 24 hours ago |
20 DMA Support | 1 day ago |
Free Daily (Stock) Chart Reading
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 05/13/2024
ARS Pharmaceuticals, Inc. develops ARS-1, a novel intranasal epinephrine spray with absorption technology for patients and their families at-risk of severe allergic reactions to food, medications, and insect bites. Its product includes Neffy, a low-dose intranasal epinephrine nasal spray. The company was incorporated in 2015 and is based in San Diego, California.
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Allergy Respiratory Therapy Respiratory Diseases Type I Hypersensitivity Allergology Nasal Administration Anaphylaxis
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Allergy Respiratory Therapy Respiratory Diseases Type I Hypersensitivity Allergology Nasal Administration Anaphylaxis
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 11.27 |
52 Week Low | 2.55 |
Average Volume | 669,413 |
200-Day Moving Average | 6.53 |
50-Day Moving Average | 9.04 |
20-Day Moving Average | 8.82 |
10-Day Moving Average | 9.15 |
Average True Range | 0.46 |
RSI (14) | 48.72 |
ADX | 13.56 |
+DI | 21.50 |
-DI | 20.42 |
Chandelier Exit (Long, 3 ATRs) | 8.41 |
Chandelier Exit (Short, 3 ATRs) | 9.05 |
Upper Bollinger Bands | 9.75 |
Lower Bollinger Band | 7.89 |
Percent B (%b) | 0.53 |
BandWidth | 21.08 |
MACD Line | 0.01 |
MACD Signal Line | 0.03 |
MACD Histogram | -0.0169 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 9.38 | ||||
Resistance 3 (R3) | 9.41 | 9.29 | 9.29 | ||
Resistance 2 (R2) | 9.29 | 9.16 | 9.27 | 9.26 | |
Resistance 1 (R1) | 9.08 | 9.08 | 9.02 | 9.05 | 9.24 |
Pivot Point | 8.96 | 8.96 | 8.93 | 8.94 | 8.96 |
Support 1 (S1) | 8.75 | 8.83 | 8.69 | 8.72 | 8.52 |
Support 2 (S2) | 8.63 | 8.75 | 8.61 | 8.50 | |
Support 3 (S3) | 8.42 | 8.63 | 8.47 | ||
Support 4 (S4) | 8.39 |